Advertisement

Early screening for gestational diabetes mellitus: a meta-analysis of randomized controlled trials

      OBJECTIVE

      Current evidence is conflicting on whether early screening and treatment for gestational diabetes mellitus improve pregnancy outcomes. Thus, this systematic review and meta-analysis of randomized controlled trials aimed to assess the rate of adverse pregnancy outcomes among participants with early screening and treatment for gestational diabetes mellitus vs those with routine care.

      DATA SOURCES

      A systematic review of the literature was conducted using MEDLINE, Scopus, ClinicalTrials.gov, EMBASE, ScienceDirect, the Cochrane Library at the Central Register of Controlled Trials, and SciELO from inception to November 2021.

      STUDY ELIGIBILITY CRITERIA

      Studies were eligible for inclusion if they described randomized controlled trials comparing early screening with routine care for gestational diabetes mellitus to assess the effects of early screening and treatment on pregnancy outcomes.

      METHODS

      All randomized controlled trials comparing early vs standard screening of gestational diabetes mellitus assessing the effect of early screening (defined as a screening at <20 weeks of gestation) vs routine screening (defined as a screening at ≥20 weeks of gestation) on pregnancy outcomes were included. The primary outcome was defined as large for gestational age, as defined by the trial. The secondary maternal and neonatal outcomes were also evaluated. Subgroup analyses were performed on the basis of screening strategy and methods.

      RESULTS

      After exclusion, 8 randomized clinical trials (1920 participants) of early screening and treatment vs standard care were included. There were a total of 746 participants with early gestational diabetes mellitus. The risk of large for gestational age at birth did not differ between early screening and treatment for gestational diabetes mellitus and routine care among all included trials (8.1 vs 9.0%; relative risk, 0.94; 95% confidence interval, 0.73–1.22). Trials with a protocol of universal screening of participants at their first prenatal visit (>80% screened with HbA1c) and receiving early treatment if the screening test returned positive had a lower risk of large for gestational age (2.3 vs 9.1%; relative risk, 0.29; 95% confidence interval, 0.09–0.90) than those who had routine screening and care.

      CONCLUSION

      Overall, early screening and treatment of gestational diabetes mellitus did not reduce the risk of large for gestational age at birth. However, trials that screened all participants at their first visit and treated early, most for an HbA1c of 5.7% to 6.4%, had a reduced risk of large for gestational age at birth compared with routine care, suggesting a possible benefit of screening all pregnant patients. However, future well-designed trials are needed to confirm these findings.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. ACOG Practice Bulletin No. 190: gestational diabetes mellitus.
        Obstet Gynecol. 2018; 131: e49-e64
        • Yogev Y
        • Xenakis EM
        • Langer O
        The association between preeclampsia and the severity of gestational diabetes: the impact of glycemic control.
        Am J Obstet Gynecol. 2004; 191: 1655-1660
        • Ehrenberg HM
        • Durnwald CP
        • Catalano P
        • Mercer BM
        The influence of obesity and diabetes on the risk of cesarean delivery.
        Am J Obstet Gynecol. 2004; 191: 969-974
        • Metzger BE
        • Lowe LP
        • et al.
        • HAPO Study Cooperative Research Group
        Hyperglycemia and adverse pregnancy outcomes.
        N Engl J Med. 2008; 358: 1991-2002
        • Rosenstein MG
        • Cheng YW
        • Snowden JM
        • Nicholson JM
        • Doss AE
        • Caughey AB
        The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes.
        Am J Obstet Gynecol. 2012; 206: e1-e7
        • Casagrande SS
        • Linder B
        • Cowie CC
        Prevalence of gestational diabetes and subsequent type 2 diabetes among U.S. women.
        Diabetes Res Clin Pract. 2018; 141: 200-208
        • Hales CM
        • Carroll MD
        • Fryar CD
        • Ogden CL
        Prevalence of obesity and severe obesity among adults: United States, 2017-2018.
        NCHS Data Brief. 2020; 360: 1-8
        • Weiss JL
        • Malone FD
        • Emig D
        • et al.
        Obesity, obstetric complications and cesarean delivery rate–a population-based screening study.
        Am J Obstet Gynecol. 2004; 190: 1091-1097
        • Hod M
        • Kapur A
        • Sacks DA
        • et al.
        The International Federation of Gynecology and Obstetrics (FIGO) Initiative on gestational diabetes mellitus: a pragmatic guide for diagnosis, management, and care.
        Int J Gynaecol Obstet. 2015; 131: S173-S211
        • Bartha JL
        • Martinez-Del-Fresno P
        • Comino-Delgado R
        Gestational diabetes mellitus diagnosed during early pregnancy.
        Am J Obstet Gynecol. 2000; 182: 346-350
        • Barahona MJ
        • Sucunza N
        • García-Patterson A
        • et al.
        Period of gestational diabetes mellitus diagnosis and maternal and fetal morbidity.
        Acta Obstet Gynecol Scand. 2005; 84: 622-627
        • Riskin-Mashiah S
        • Younes G
        • Damti A
        • Auslender R
        First-trimester fasting hyperglycemia and adverse pregnancy outcomes.
        Diabetes Care. 2009; 32: 1639-1643
        • Mañé L
        • Flores-Le Roux JA
        • Benaiges D
        • et al.
        Role of first-trimester HbA1c as a predictor of adverse obstetric outcomes in a multiethnic cohort.
        J Clin Endocrinol Metab. 2017; 102: 390-397
        • Salman L
        • Arbib N
        • Borovich A
        • et al.
        The impact of first trimester fasting glucose level on adverse perinatal outcome.
        J Perinatol. 2018; 38: 451-455
        • Liu B
        • Cai J
        • Xu Y
        • et al.
        Early diagnosed gestational diabetes mellitus is associated with adverse pregnancy outcomes: a prospective cohort study.
        J Clin Endocrinol Metab. 2020; 105: dgaa633
        • American Diabetes Association
        14. Management of diabetes in pregnancy: standards of medical care in Diabetes-2020.
        Diabetes Care. 2020; 43: S183-S192
        • Crowther CA
        • Hiller JE
        • Moss JR
        • et al.
        Effect of treatment of gestational diabetes mellitus on pregnancy outcomes.
        N Engl J Med. 2005; 352: 2477-2486
        • Landon MB
        • Spong CY
        • Thom E
        • et al.
        A multicenter, randomized trial of treatment for mild gestational diabetes.
        N Engl J Med. 2009; 361: 1339-1348
        • US Preventive Services Task Force
        Davidson KW, Barry MJ, et al. Screening for gestational diabetes: US Preventive Services Task Force recommendation statement.
        JAMA. 2021; 326: 531-538
        • Raets L
        • Beunen K
        • Benhalima K
        Screening for gestational diabetes mellitus in early pregnancy: what is the evidence?.
        J Clin Med. 2021; 10: 1257
        • De Muylder X
        Perinatal complications of gestational diabetes: the influence of the timing of the diagnosis.
        Eur J Obstet Gynecol Reprod Biol. 1984; 18: 35-42
        • Hawkins JS
        • Lo JY
        • Casey BM
        • McIntire DD
        • Leveno KJ
        Diet-treated gestational diabetes mellitus: comparison of early vs routine diagnosis.
        Am J Obstet Gynecol. 2008; 198: e1-e6
        • Boriboonhirunsarn D
        • Sunsaneevithayakul P
        • Pannin C
        • Wamuk T
        Prevalence of early-onset GDM and associated risk factors in a university hospital in Thailand.
        J Obstet Gynaecol. 2021; 41: 915-919
        • Clarke E
        • Cade TJ
        • Brennecke S
        Early pregnancy screening for women at high-risk of GDM results in reduced neonatal morbidity and similar maternal outcomes to routine screening.
        J Pregnancy. 2020; 20209083264
        • Cosson E
        • Vicaut E
        • Berkane N
        • et al.
        Prognosis associated with initial care of increased fasting glucose in early pregnancy: a retrospective study.
        Diabetes Metab. 2021; 47101197
        • Alunni ML
        • Roeder HA
        • Moore TR
        • Ramos GA
        First trimester gestational diabetes screening - change in incidence and pharmacotherapy need.
        Diabetes Res Clin Pract. 2015; 109: 135-140
        • Sweeting AN
        • Ross GP
        • Hyett J
        • et al.
        Gestational diabetes mellitus in early pregnancy: evidence for poor pregnancy outcomes despite treatment.
        Diabetes Care. 2016; 39: 75-81
        • Hosseini E
        • Janghorbani M
        • Shahshahan Z
        Comparison of risk factors and pregnancy outcomes of gestational diabetes mellitus diagnosed during early and late pregnancy.
        Midwifery. 2018; 66: 64-69
        • Bianchi C
        • de Gennaro G
        • Romano M
        • et al.
        Early vs. standard screening and treatment of gestational diabetes in high-risk women - an attempt to determine relative advantages and disadvantages.
        Nutr Metab Cardiovasc Dis. 2019; 29: 598-603
      2. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook. Accessed May 15, 2022.

        • Moher D
        • Liberati A
        • Tetzlaff J
        • Altman DG
        PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        J Clin Epidemiol. 2009; 62: 1006-1012
        • Sterne JAC
        • Savović J
        • Page MJ
        • et al.
        RoB 2: a revised tool for assessing risk of bias in randomised trials.
        BMJ. 2019; 366: l4898
        • Osmundson SS
        • Norton ME
        • El-Sayed YY
        • Carter S
        • Faig JC
        • Kitzmiller JL
        Early screening and treatment of women with prediabetes: a randomized controlled trial.
        Am J Perinatol. 2016; 33: 172-179
        • Hughes RCE
        • Rowan J
        • Williman J
        Prediabetes in pregnancy, can early intervention improve outcomes? A feasibility study for a parallel randomised clinical trial.
        BMJ Open. 2018; 8e018493
        • Simmons D
        • Nema J
        • Parton C
        • et al.
        The treatment of booking gestational diabetes mellitus (TOBOGM) pilot randomised controlled trial.
        BMC Pregnancy Childbirth. 2018; 18: 151
        • Vinter CA
        • Tanvig MH
        • Christensen MH
        • et al.
        Lifestyle intervention in Danish obese pregnant women with early gestational diabetes mellitus according to WHO 2013 criteria does not change pregnancy outcomes: results from the LiP (lifestyle in pregnancy) study.
        Diabetes Care. 2018; 41: 2079-2085
        • Roeder HA
        • Moore TR
        • Wolfson MT
        • Gamst AC
        • Ramos GA
        Treating hyperglycemia in early pregnancy: a randomized controlled trial.
        Am J Obstet Gynecol MFM. 2019; 1: 33-41
        • Harper LM
        • Jauk V
        • Longo S
        • Biggio JR
        • Szychowski JM
        • Tita AT
        Early gestational diabetes screening in obese women: a randomized controlled trial.
        Am J Obstet Gynecol. 2020; 222: e1-e8
        • Enakpene CA
        • M Della Torre
        • DiGiovanni L
        • et al.
        Randomization of early diabetes screening among obese pregnant women (REDSOAP study).
        Am J Obstet Gynecol. 2022; 226: S42
        • Rodriguez A
        • Delgado A
        • Pressman K
        • Louis J
        Early gestational diabetes screening in women at risk for gestational diabetes: a randomized controlled trial.
        Am J Obstet Gynecol. 2022; 226: S41
        • Vinter CA
        • Jensen DM
        • Ovesen P
        • Beck-Nielsen H
        • Jørgensen JS.
        The LiP (Lifestyle in Pregnancy) study: a randomized controlled trial of lifestyle intervention in 360 obese pregnant women.
        Diabetes Care. 2011; 34: 2502-2507
      3. Nankervis A, McIntyre HD, Moses R, et al. ADIPS consensus guidelines for the testing and diagnosis of gestational diabetes mellitus in Australia and New Zealand. 2014. Available at: http://adips.org/downloads/2014ADIPSGDMGuidelinesV18.11.2014_000.pdf. Accessed January 28, 2022.

        • Song X
        • Chen L
        • Zhang S
        • et al.
        High maternal triglyceride levels mediate the association between pre-pregnancy overweight/obesity and macrosomia among singleton term non-diabetic pregnancies: a prospective cohort study in central China.
        Nutrients. 2022; 14: 2075